
ã¡ã¿ã«åã®ã仿¥ã®ç²Ÿç¥å»åŠè±ç¥èïŒã(446)-(450)
çæ§ãããã«ã¡ã¯ãé¹¿å¶æ¢ä»(ããã»ããã)ã§ãð
GWã«çªå ¥ããŸãããïŒ
å é±ã®èšäºã§ãã玹ä»ããŸãããæãå®¶ã¯é åºçã¯ãããè¿å Žã«ã¡ããã¡ãããåºãããããããšæã£ãŠããŸãâºïž
å®¶ã§ã¯noteå·ç以å€ã«ã¯æè¿çãã«ããŠããã€ã³ããããç¹ã«è²·ãã ããŠããæ¬ãèªããããšæã£ãŠããŸãð
Amazonãæžåºã§ãžã£ã±è²·ãããæ¬ãã¡ãããã£ããèªãã§ããããããð
ã¡ã¿ã«åã®ã仿¥ã®ç²Ÿç¥å»åŠè±ç¥èïŒãã¯ãX(æ§: twitter)ã§æ¯æ8æã«ã¢ããããŠãããŸãã
X(æ§: twitter)æ°ã®çæ§ããX(æ§: twitter)ã§ã¯èªããããªãã£ããã¡ã¿ã«ã®ããŸãããããããŸãã®ã§ããèå³ãããã°æ¬èšäºãæ¯éãèªã¿ãã ããïŒ
ã仿¥ã®ç²Ÿç¥å»åŠè±ç¥èéïŒ(ãã®90)ã
446.TCAã¯äžç°ç³»æãã€å€(TriCyclic Antidepressants)ã®ç¥ã ããTCAã¯å€ãããããè¬ã ãã©ãå¯äœçšã匷ããŠä»ã§ã¯ä»ã®æãã€å€ã«ç¬¬äžéžæè¬ã®åº§ã奪ãããŠãããã©ãéçäŸã«ã€ãŠãã¯TCAãæå¹ãªå ŽåãããããããŸã ã«éå®ãããŠãããã
ãã¡ã¿ã«ã®ããŸãã
TCAã®å©ç¹ã¯ä»ã«ããã£ãŠãäŸãã°TCAã®ã¯ãããã©ãã³(ã¢ããã©ããŒã«)ã«ã¯ç¹æ»Žå€ãããã(ä»ã®æãã€å€ã«ã¯ç¹æ»Žå€ã¯ãªãã)ããã€ç¶æ
ãã²ã©ããŠè¬ãåŸåæåã§ããªãæãã¯ãããã©ãã³ã®ç¹æ»ŽãããçšããŠãããª...(æè¿ã¯åºçªããããªãïŒ)ð€
âç¹æ»Žã泚å°ã®ç·Žç¿ã»ããã ããã§ãïŒ
447.SSRIã¯éžæçã»ãããã³ååã蟌ã¿é»å®³è¬(Selective Serotonin Reuptake Inhibitors)ã®ç¥ã ããä»ã§ã¯ãã€ç ã®è¬ç©çæ³ã®ç¬¬äžéžæè¬ãšããŠäœ¿çšãããŠãããããã®çç±ã¯è¬å¹ã¯å¿è«ã ãã©ãå¯äœçšãåŸæ¥ã®æãã€å€ããå°ãªãããã ãã
ãã¡ã¿ã«ã®ããŸãã
SSRIã販売ãããã®ã¯1988幎ã®ãã«ãªãã»ãã³(ããã¶ãã¯)ãæåã ããã§ãæ¥æ¬ã§ã¯èªå¯ãããããã«ãããµãã³(ã«ããã¯ã¹ã»ãããã¡ãŒã«)ãæ¥æ¬ã§æåã«çºå£²ãããSSRIãªãã ã(1999)ããšããã§ããªãã¢ã ãã©ããã«ãªãã»ãã³ãäºæè²ã«äžãããšç¹æ®åã2åã«ãªãã£ãŠã...ããã®ææã«ããç ç©¶è
ããŒã¿ãŒã»ãã©ã³ã°ã¯ã€ã°ããŒãã«è³ãåè³ããã£ãŠãïŒ
âã€ã°ããŒãã«è³ã®ç ç©¶ã玹ä»ããæ¬ã ããã§ãïŒ
448.SNRI(Serotonin and norepinephrine reuptake inhibitors)ã¯ã»ãããã³ã ãã§ãªããã«ã¢ãã¬ããªã³ã®éåã蟌ã¿ãé»å®³ããæãã€å€ã ããSSRIãšSNRIã®äœ¿ãåãã«å€§ããªéãã¯ãªããã©åè ã¯äžå®ã匷ãã¿ã€ããåŸè ã¯ææ¬²äœäžã忝ã«ããã¿ã€ãã®ãã€ç ã«äœ¿ãããšãå€ãããªã
ãã¡ã¿ã«ã®ããŸãã
SNRIã¯æ¥æ¬ã§ã¯3çš®é¡ã®ã¿è²©å£²ãããŠããŠããã«ãã·ãã©ã³(ãã¬ããã³)ããã¥ããã»ãã³(ãµã€ã³ãã«ã¿)ããã³ã©ãã¡ãã·ã³(ã€ãã§ã¯ãµãŒ)ã䜿ããããåã®æè§Šçã«ã¯ãµã€ã³ãã«ã¿ãšã€ãã§ã¯ãµãŒã1æ¥1ååŠæ¹ãªã®ã§äœ¿ãåæãããããäžæ¹ããã¬ããã³ã¯1æ¥2-3åã«åããŠé£²ããããã¢ããã¢ã©ã³ã¹çã«ããé£ããã ãð€
âãåç¥ãã¢ãã¢ãã³ç³»ã®Tã·ã£ãã§ãïŒãã«ã¢ãã¬ããªã³ããããŸããã
449.NaSSAã¯ãã«ã¢ãã¬ããªã³äœåæ§ã»ç¹ç°çã»ãããã³äœçšæ§æãã€è¬(Noradrenergic and Specific Serotonergic Antidepressant)ã®ç¥ã ããæ¥æ¬ã§ã¯ãã«ã¿ã¶ãã³(ãªãã¬ãã¯ã¹ãªã©)ã䜿çšãããŠãããã©ç æ°ãåºãããããå¯ãåã«æäžãããã
ãã¡ã¿ã«ã®ããŸãã
ãã«ã¿ã¶ãã³ã¯äžç ãçŠç¥ã匷ãã¿ã€ãã®é¬±ç
ã«ãã䜿ããããã1æ¥1ååŠæ¹ã§ãåãæ°ã飿¬²äœäžãæ§æ©èœäœäžãªã©æãã€å€ã§ãã°ãã°èŠãããå¯äœçšãå°ãªãããã§ãããã«ã¿ã¶ãã³ã飲ããšå€ªãããããªããã
âããã¯NaSSAã§ã¯ãªããNASAã§ãã
450.MAOIã¯(MonoAmine Oxidase Inhibitor)ã®ç¥ã§ã¢ãã¢ãã³ãåè§£ããMAOãšããé µçŽ ãé»å®³ããããæ¥æ¬ã§ã以åæãã€å€ãšããŠäœ¿çšãããŠãããã©çŸåšã¯äœ¿ãããŠããªãã(æµ·å€ã§ã¯äœ¿çš)ãã§ãéå®åãã€ç ã«å¹æããããšèšãããŠãããæ¥æ¬ã§ã䜿çšã§ãããšãããã
ãã¡ã¿ã«ã®ããŸãã
ç±³åœFDAã§ã¯Isocarboxazid (Marplan)ãPhenelzine (Nardil)ãSelegiline (Emsam)ãTranylcypromine (Parnate)ã®4çš®é¡ã®MAOIãæãã€å€ãšããŠé©å¿ãããŠããããã¡ãªã¿ã«æ¥æ¬ã§ã¯Selegilineã¯ããŒãã³ãœã³ç
ã®è¬ãšããŠäœ¿çšãããŠãããã©ããã€ç
ãžã®ä¿éºé©å¿ã¯ãªããã
âMAOã§æ€çŽ¢ãããããµã³ããŒã«é£èŒããŠããæŒ«ç»ãåºãŠããŸãã(å°çæªèªã§ãã)ïŒ
ãã¡ã¿ã«åã®èå¯ã
ä»åã¯ãæãã€å€ã®ç¥èªãã«é¢ããŠãã€ãŒããããïŒ
éå»çåŸäºè ã¯ããŸãèãæ £ããªããããããªããã©ãäžèšã®ç¥èªã¯å²ãšèšåºã§ã¯ãã䜿ãç¥èªã ãã
æãã€å€ã¯è¬çäœçšã«ãã£ãŠäžèšã®ããã«åé¡ããããã©ãåºæ¬çã«ã¯ã»ãããã³ã®ã·ããã¹éæ¿åºŠãäžæãããããšã¯å ±éã ãã
ãã ãæµ·å€ã«ã¯ãããããªã³ãšãããã«ãšããããªã³ã»ãããã³ååã蟌ã¿é»å®³è¬(NDRI)ãäžåžãããŠãããã©ããã®è¬å€ã¯ã»ãããã³ãšã¯ããŸãé¢ä¿ãªããïŒ
ãããããã©ãã©ãããã¢ãã¯ãªç²Ÿç¥å»åŠãã¿ãæäŸãããïŒ
âã¹ã©ã€ã ã®Tã·ã£ããã»ããïŒð
ãX(Twitter)ã
X(Twitter)ããã£ãŠããŸãïŒå®ããã°ã絡ãã§ãã ãããªâºïž
ç§ã«ã€ããŠ(èªå·±ç޹ä»):é¹¿å¶æ¢ä»(ããã»ããã)ïœé¹¿å¶æ¢ä»(ããã»ããã) @kayahosuke #note https://t.co/Jk47SAeCB7
â 粟ç¥ç§å»ã»é¹¿å¶æ¢ä»(ããã»ããã) (@kayahosuke) March 22, 2022
noteã§ç§ã®ãããã£ãŒã«ã®è©³çŽ°ãæžããŸããããããããã°ããã¹ããããŠãã ããã#èªå·±çŽ¹ä» #note #粟ç¥ç§å»
ããã¡ããããããã
ãã®èšäºãåå ããŠããåé
- #note
- #èªå·±ç޹ä»
- #å¥åº·
- #å¿çåŠ
- #æè¿ã®åŠã³
- #ç§ã®ä»äº
- #ã¡ã³ã¿ã«ãã«ã¹
- #ç é¢
- #å»ç
- #ç§åŠ
- #å»åž«
- #粟ç¥ç§
- #X
- #ãµã€ãšã³ã¹
- #ãã«ã¹ã±ã¢
- #è±ç¥è
- #å»åŠ
- #粟ç¥ç§å»
- #ããªãã¢
- #粟ç¥å»åŠ
- #æ¢æ±åŠç¿ããã
- #å åææ
- #ãã€ãŒããŸãšã
- #ã¡ã¿ã«ã¹ã©ã€ã
- #SSR
- #ã¡ã¿ã«å
- #ã¡ã¿ã«ã¹ã©ã€ã ãšç²Ÿç¥å»åŠ
- #ã¡ã¿ã«åã®ä»æ¥ã®ç²Ÿç¥å»åŠè±ç¥è
- #SNRI
- #TCA
- #NASSA
- #éžæçã»ãããã³ååã蟌ã¿é»å®³è¬
- #maoi
- #äžç°ç³»æãã€å€
- #æãã€å€ã®ç¥èª